Cargando…

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39% (95% confidence interval: 20–54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41% for current and any prior doses, 67% for current vaccina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castilla, Jesús, Navascués, Ana, Casado, Itziar, Pérez-García, Alejandra, Aguinaga, Aitziber, Ezpeleta, Guillermo, Pozo, Francisco, Ezpeleta, Carmen, Martínez-Baz, Iván
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2018
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824126/ https://www.ncbi.nlm.nih.gov/pubmed/29471624 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.7.18-00057

Ejemplares similares

Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis
por: Castilla, Jesús, et al.
Publicado: (2017)

Simple models to include influenza vaccination history when evaluating the effect of influenza vaccination
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22
por: Martínez-Baz, Iván, et al.
Publicado: (2022)

Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16
por: Castilla, Jesús, et al.
Publicado: (2018)

Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023
por: Martínez-Baz, Iván, et al.
Publicado: (2023)

Detection of Respiratory Viruses in Deceased Persons, Spain, 2017
por: Navascués, Ana, et al.
Publicado: (2018)

Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022
por: Castilla, Jesús, et al.
Publicado: (2022)

Chronic obstructive pulmonary disease and influenza vaccination effect in preventing outpatient and inpatient influenza cases
por: Martínez-Baz, Iván, et al.
Publicado: (2022)

Effect of influenza vaccination in patients with asthma
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Household Transmission of Influenza A(H1N1)pdm09 in the Pandemic and Post-Pandemic Seasons
por: Casado, Itziar, et al.
Publicado: (2014)

Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain
por: Juanbeltz, Regina, et al.
Publicado: (2018)

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Mycoplasma pneumoniae y resistencias a macrólidos: ¿Conocemos la situación en Europa?
por: Varela, Ana Isabel Álvaro, et al.
Publicado: (2023)

Artritis meningocócica primaria
por: Machain, Estibaliz Erviti, et al.
Publicado: (2021)

Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers
por: Martínez-Baz, Iván, et al.
Publicado: (2020)

Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
por: Kissling, Esther, et al.
Publicado: (2019)

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
por: Rondy, Marc, et al.
Publicado: (2018)

Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017
por: Adelantado, Marta, et al.
Publicado: (2019)

Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017
por: Sullivan, Sheena G, et al.
Publicado: (2017)

Interim estimate of influenza vaccine effectiveness in hospitalised children, Hong Kong, 2017/18
por: Chiu, Susan S, et al.
Publicado: (2018)

Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study
por: Martínez-Baz, Iván, et al.
Publicado: (2023)

Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2022)

Influenza B vaccine lineage selection—An optimized trivalent vaccine
por: Mosterín Höpping, Ana, et al.
Publicado: (2016)

Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study
por: Castilla, Jesús, et al.
Publicado: (2015)

Trends and causes of mortality in a population-based cohort of HIV-infected adults in Spain: comparison with the general population
por: Fontela, Carmen, et al.
Publicado: (2020)

Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case–control study
por: Martínez-Baz, Iván, et al.
Publicado: (2013)

Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study
por: Castilla, Jesús, et al.
Publicado: (2021)

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Vaccine effectiveness against influenza A(H3N2) and B among laboratory‐confirmed, hospitalised older adults, Europe, 2017‐18: A season of B lineage mismatched to the trivalent vaccine
por: Rose, Angela M. C., et al.
Publicado: (2020)

Utility of a commercial RT-qPCR assay to detect SARS-CoV-2 gene variations as an indicator of lineages
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2022)

A late sharp increase in influenza detections and low interim vaccine effectiveness against the circulating A(H3N2) strain, Denmark, 2021/22 influenza season up to 25 March 2022
por: Emborg, Hanne-Dorthe, et al.
Publicado: (2022)

Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020
por: Skowronski, Danuta M, et al.
Publicado: (2020)

Influenza A(H5N1) detection in two asymptomatic poultry farm workers in Spain, September to October 2022: suspected environmental contamination
por: Aznar, Esteban, et al.
Publicado: (2023)

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018
por: Skowronski, Danuta M, et al.
Publicado: (2018)

Detection of West Nile virus lineage 2 in North‐Eastern Spain (Catalonia)
por: Busquets, Núria, et al.
Publicado: (2018)

Criptosporidiosis en paciente inmunodeprimida por trasplante renal
por: Garcia, Irati Arregui, et al.
Publicado: (2021)

Highly pathogenic avian influenza A(H5N1) virus infection in farmed minks, Spain, October 2022
por: Agüero, Montserrat, et al.
Publicado: (2023)

Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children
por: Viguria, Natividad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a716nveaaj1m98sp71jnep7v8e